National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

therapeutic hemin
A sterile, lyophilized powder of hemin, the Fe3+ oxidation product of heme (Fe2+), derived from processed red blood cells. Therapeutic hemin appears to inhibit delta-aminolevulinic acid (ALA) synthetase, a rate-limiting enzyme in the porphyrin/heme biosynthetic pathway, resulting in inhibition of the hepatic and/or marrow synthesis of porphyrin precursors. The mechanism by which therapeutic hematin produces symptomatic improvement in patients with acute episodes of the hepatic porphyrias has not been determined. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Panhematin



Previous:therapeutic autologous lymphocytes, therapeutic dehydroepiandrosterone, therapeutic epinephrine, therapeutic estetrol, therapeutic estradiol
Next:therapeutic hydrocortisone, therapeutic immune globulin, therapeutic melatonin, therapeutic progesterone, therapeutic testosterone

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov